mdlinx mdlinx

Gastroenterology - GI Oncology News & Articles

Available now at MDLinx Gastroenterology: Ranked summaries of the most clinically-relevant GI literature refreshed every 24 hours, as well as MDLinx Gastroenterology exclusive content

  • Our team of dedicated physician medical editors sort, rank and summarize articles in over 2,000 medical journals to bring you the key developments in your uniquely diverse field. In addition to general gastroenterology news, you'll find subspecialty coverage of the biliary system and pancreas, colorectal cancer and polyps, hepatology and liver disease, GI bleeding, GI infectious diseases, gastrointestinal endoscopy, obesity, parenteral and enteral nutrition, diagnostic imaging, and more.
  • MDLinx Gastroenterology exclusive content includes: Monthly highlights of the "can't miss" articles chosen by our physician editor, D. Scott Cunningham, MD, PhD; clinical pearls from The Smartest Internist and Smartest Family Physician daily competitions, a collaboration from the editors of MDLinx and Cleveland Clinic Center for Continuing Education; and pearls from our Pediatrics Physician Review quizzes.

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (19) Full Text Articles (318)
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic barretts esophagus Clinical Gastroenterology and Hepatology , May 22, 2013    Clinical Article

2 Metformin use and improved response to therapy in esophageal adenocarcinoma Acta Oncologica, May 22, 2013    Clinical Article

3 Key factors influencing prognosis in relation to gallbladder cancer Digestive Diseases and Sciences, May 22, 2013    Clinical Article

4 Outcome comparisons among the hangzhou, chengdu, and ucsf criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies Journal of Gastrointestinal Surgery, May 22, 2013    Clinical Article

5 18-fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma Clinical Gastroenterology and Hepatology , May 22, 2013    Clinical Article

6 Rarity of severe bleeding and perforation in endoscopic ultrasound-guided fine needle aspiration for submucosal tumors Digestive Diseases and Sciences, May 22, 2013    Clinical Article

7 The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer Medical Oncology, May 22, 2013    Clinical Article

8 Monoclonal antibodies in gastrointestinal cancers Expert Opinion on Biological Therapy, May 22, 2013    Review Article

9 Circulating micrornas as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Clinical Gastroenterology and Hepatology , May 22, 2013    Review Article

10 Risk prediction of esophageal squamous-cell carcinoma with common genetic variants and lifestyle factors in Chinese population Carcinogenesis, May 22, 2013    Review Article

11 The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma Tumor Biology, May 22, 2013    Clinical Article

12 Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma Tumor Biology, May 22, 2013    Clinical Article

13 Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas Digestive Diseases and Sciences, May 22, 2013    Clinical Article

14 MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression Carcinogenesis, May 22, 2013    Review Article

15 Simple pathological examination technique for detection of cancer located at the surgical margin of the stomach Gastric Cancer, May 22, 2013    Review Article

16 High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma Medical Oncology, May 22, 2013    Clinical Article

17 Histological and prognostic importance of CD44+/CD24+/EpCAM+ expression in clinical pancreatic cancer Cancer Science, May 22, 2013    Clinical Article

18 A case of perianal mucinous adenocarcinoma arising from an anorectal fistula successfully resected after preoperative radiotherapy Full Text Case Reports in Gastroenterology, May 22, 2013

19 Ganglioneuroma in the papilla of Vater with neurofibromatosis type 1: report of a case Surgery Today, May 22, 2013

Prior Articles

20 Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies Full Text World Journal of Gastroenterology, May 21, 2013    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Gastroenterology

Highlights in Gastroenterology

What is the best strategy for CRC screening?

As published in the NEJM, researchers in the COLONPREV study (Spain) have reported that fecal immunochemical testing (FIT) is as effective as colonoscopy in the detection of colorectal cancer (CRC). The study population was 50-69 years of age and comprised of 26,703 subjects who underwent a one-time colonoscopy and 26,599 subjects who underwent FIT every 2 years. The primary outcome measure was CRC deaths at 10 years. Participation in screening was greater in the FIT group than the colonoscopy group (34.2% vs. 24.6%). Detection of CRC was similar between the two groups (0.1%). Advanced and non-advanced adenomas were detected more frequently in the colonoscopy group than the FIT group (1.9% vs. 0.9% [OR=2.3] and 4.2% vs. 0.4% [OR=9.8], respectively).

Read the article summary

PPIs increase risk of Clostridium difficile infection

Based on a meta-analysis involving 30 observational studies and 202,965 patients, proton pump inhibitor therapy has been shown to significantly increase the risk of infection with Clostridium difficile (OR = 2.15).

Read the article summary

Metformin improves survival in patients with DM and CRC

In a single institution study involving 424 patients with DM and CRC, those patients treated with metformin had a 30% improvement in OS compared with patients not treated with metformin. Specifically, the metformin-treated patients had a mean survival of 76.9 months compared to 56.9 months.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Gastroenterology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close